Publication Results

Generate Report

Add publications by marking their checkboxes, or

Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA.

Gao CF,  Wisniewski LB,  Liu Y,  Staal B,  Beddows I,  Plenker D,  Aldakkak M,  Hall J,  Barnett D,  Kheir Gouda M,  Allen PJ,  Drake RR,  Zureikat AH,  Huang Y,  Evans DB,  Singhi AD,  Brand RE,  Tuveson DA,  Tsai S,  Haab BB
Clin Cancer Res 2020 Oct 22
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 33093149
PMC ID: not available

Mg2+ regulation of kinase signaling and immune function.

Kanellopoulou C,  George AB,  Masutani E,  Cannons JL,  Ravell JC,  Yamamoto TN,  Smelkinson MG,  Jiang PD,  Matsuda-Lennikov M,  Reilley J,  Handon R,  Lee PH,  Miller JR,  Restifo NP,  Zheng L,  Schwartzberg PL,  Young M,  Lenardo MJ
J Exp Med 2019 Aug 5;216(8):1828-1842
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31196981
PMC ID: PMC6683994

Liquid biopsy: a holy grail for cancer detection.

Sorbara L,  Srivastava S
Biomark Med 2019 Aug;13(12):991-994
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31464153
PMC ID: not available

Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.

He HJ,  Stein EV,  Konigshofer Y,  Forbes T,  Tomson FL,  Garlick R,  Yamada E,  Godfrey T,  Abe T,  Tamura K,  Borges M,  Goggins M,  Elmore S,  Gulley ML,  Larson JL,  Ringel L,  Haynes BC,  Karlovich C,  Williams PM,  Garnett A,  StÃ¥hlberg A,  Filges S,  Sorbara L,  Young MR,  Srivastava S,  Cole KD
J Mol Diagn 2019 Jul;21(4):658-676
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31055023
PMC ID: PMC6626992

Cancer overdiagnosis: a biological challenge and clinical dilemma.

Srivastava S,  Koay EJ,  Borowsky AD,  De Marzo AM,  Ghosh S,  Wagner PD,  Kramer BS
Nat Rev Cancer 2019 Jun;19(6):349-358
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 31024081
PMC ID: not available

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities (vol 4, pg 523, 2018)

Srivastava Sudhir,  Ghosh Sharmistha,  Kagan Jacob,  Mazurchuk Richard,  Boja Emily,  Ossandon Miguel,  Chuaqui Rodrigo,  Rosenfield Sonia,  Chavarria-Johnson Eric,  Samimi Goli,  Davidsen Tanja,  Shern Jack,  Eary Janet,  Star Rob,  Haim Todd,  Takebe Naoko,  Hanlon Sean,  Tavares Norbert,  Hewitt Stephen,  Tricoli James,  Hughes Shannon,  Trimble Ted,  Jacobs Paula,  Umar Asad,  Li Jerry,  Velazquez Jose,  Lively Tracy,  Wang Chiayeng,  Lockett Stephen,  Zenklusen J. C.,  Misteli Tom,  Oberdoerffer Philipp,  Nelson Stefanie,  Lee Jerry,  Odeh Hana,  Kenney Nicholas
Trends Cancer 2019 Apr;5(4):263-263
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: not available
PMC ID: not available

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Yang JD,  Addissie BD,  Mara KC,  Harmsen WS,  Dai J,  Zhang N,  Wongjarupong N,  Ali HM,  Ali HA,  Hassan FA,  Lavu S,  Cvinar JL,  Giama NH,  Moser CD,  Miyabe K,  Allotey LK,  Algeciras-Schimnich A,  Theobald JP,  Ward MM,  Nguyen MH,  Befeler AS,  Reddy KR,  Schwartz M,  Harnois DM,  Yamada H,  Srivastava S,  Rinaudo JA,  Gores GJ,  Feng Z,  Marrero JA,  Roberts LR
Cancer Epidemiol Biomarkers Prev 2019 Mar;28(3):531-538
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30464023
PMC ID: PMC6401221

Carrier-Assisted Single-Tube Processing Approach for Targeted Proteomics Analysis of Low Numbers of Mammalian Cells.

Zhang P,  Gaffrey MJ,  Zhu Y,  Chrisler WB,  Fillmore TL,  Yi L,  Nicora CD,  Zhang T,  Wu H,  Jacobs J,  Tang K,  Kagan J,  Srivastava S,  Rodland KD,  Qian WJ,  Smith RD,  Liu T,  Wiley HS,  Shi T
Anal Chem 2019 Jan 15;91(2):1441-1451
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30557009
PMC ID: PMC6555634

Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.

Borges KA,  Dai J,  Parikh ND,  Schwartz M,  Nguyen MH,  Roberts LR,  Befeler AS,  Srivastava S,  Rinaudo JA,  Feng Z,  Marrero JA,  Reddy KR
Contemp Clin Trials 2019 Jan;76:49-54
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30439517
PMC ID: PMC7086481

Validation of a novel model for the early detection of hepatocellular carcinoma.

Hemken PM,  Sokoll LJ,  Yang X,  Dai J,  Elliott D,  Gawel SH,  Lucht M,  Feng Z,  Marrero JA,  Srivastava S,  Chan DW,  Davis GJ
Clin Proteomics 2019;16:2
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30675135
PMC ID: PMC6334458

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Fisher WE,  Cruz-Monserrate Z,  McElhany AL,  Lesinski GB,  Hart PA,  Ghosh R,  Van Buren G,  Fishman DS,  Rinaudo JAS,  Serrano J,  Srivastava S,  Mace T,  Topazian M,  Feng Z,  Yadav D,  Pandol SJ,  Hughes SJ,  Liu RY,  Lu E,  Orr R,  Whitcomb DC,  Abouhamze AS,  Steen H,  Sellers ZM,  Troendle DM,  Uc A,  Lowe ME,  Conwell DL,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1213-1221
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325860
PMC ID: PMC6197069

Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Hart PA,  Andersen DK,  Mather KJ,  Castonguay AC,  Bajaj M,  Bellin MD,  Bradley D,  Contreras N,  Habtezion A,  Korc M,  Kudva Y,  Petrov MS,  Whitcomb DC,  Yadav D,  Yuan Y,  Rinaudo JAS,  Srivastava S,  Serrano J,  Goodarzi MO,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1239-1243
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325863
PMC ID: PMC6195331

A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Maitra A,  Sharma A,  Brand RE,  Van Den Eeden SK,  Fisher WE,  Hart PA,  Hughes SJ,  Mather KJ,  Pandol SJ,  Park WG,  Feng Z,  Serrano J,  Rinaudo JAS,  Srivastava S,  Chari ST,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1244-1248
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325864
PMC ID: PMC6432934

Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality.

Serrano J,  Andersen DK,  Forsmark CE,  Pandol SJ,  Feng Z,  Srivastava S,  Rinaudo JAS,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1208-1212
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325859
PMC ID: PMC6195329

PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Yadav D,  Park WG,  Fogel EL,  Li L,  Chari ST,  Feng Z,  Fisher WE,  Forsmark CE,  Jeon CY,  Habtezion A,  Hart PA,  Hughes SJ,  Othman MO,  Rinaudo JAS,  Pandol SJ,  Tirkes T,  Serrano J,  Srivastava S,  Van Den Eeden SK,  Whitcomb DC,  Topazian M,  Conwell DL,  Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
Pancreas 2018 Nov-Dec;47(10):1229-1238
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30325862
PMC ID: PMC6619499

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.

Xiao Q,  Sun Y,  Dobi A,  Srivastava S,  Wang W,  Srivastava S,  Ji Y,  Hou J,  Zhao GP,  Li Y,  Li H
Sci Rep 2018 Aug 27;8(1):12868
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30150711
PMC ID: PMC6110738

The PreCancer Atlas (PCA).

Srivastava S,  Ghosh S,  Kagan J,  Mazurchuk R
Trends Cancer 2018 Aug;4(8):513-514
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 30064657
PMC ID: not available

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities.

Srivastava S,  Ghosh S,  Kagan J,  Mazurchuk R,  National Cancer Institute's HTAN Implementation
Trends Cancer 2018 Aug;4(8):523-536
Major Program(s) or Research Group(s): Breast and Gynecologic CancerCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: 30064661
PMC ID: not available

Cell-based reference samples designed with specific differences in microRNA biomarkers.

Pine PS,  Lund SP,  Stass SA,  Kukuruga D,  Jiang F,  Sorbara L,  Srivastava S,  Salit M
BMC Biotechnol 2018 Mar 20;18(1):17
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29554888
PMC ID: PMC5859499

Summarizing performance for genome scale measurement of miRNA: reference samples and metrics.

Pine PS,  Lund SP,  Parsons JR,  Vang LK,  Mahabal AA,  Cinquini L,  Kelly SC,  Kincaid H,  Crichton DJ,  Spira A,  Liu G,  Gower AC,  Pass HI,  Goparaju C,  Dubinett SM,  Krysan K,  Stass SA,  Kukuruga D,  Van Keuren-Jensen K,  Courtright-Lim A,  Thompson KL,  Rosenzweig BA,  Sorbara L,  Srivastava S,  Salit ML
BMC Genomics 2018 Mar 6;19(1):180
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29510677
PMC ID: PMC5838960

Validation: a critical step in bringing biomarkers to clinical fruition.

Srivastava S,  Kramer BS
Ann Epidemiol 2018 Feb;28(2):135-138
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Office of the Director
PubMed ID: 29157735
PMC ID: not available

Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.

Young MR,  Wagner PD,  Ghosh S,  Rinaudo JA,  Baker SG,  Zaret KS,  Goggins M,  Srivastava S
Pancreas 2018 Feb;47(2):135-141
Major Program(s) or Research Group(s): BiometryCancer Biomarkers
PubMed ID: 29346214
PMC ID: PMC5777224

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Jia L,  Lin H,  Oppenheim J,  Howard OMZ,  Li J,  Fan H,  Zhao Z,  Farrar W,  Zhang Y,  Colburn N,  Young MR,  Li W,  Newman D,  O'Keefe BR,  Beutler J,  Liu J,  Hao X,  Yang X,  Ji T,  White JD
J Natl Cancer Inst Monogr 2017 Nov 1;2017(52)
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29140488
PMC ID: PMC6279266

Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities.

Liu CH,  Abrams ND,  Carrick DM,  Chander P,  Dwyer J,  Hamlet MRJ,  Macchiarini F,  PrabhuDas M,  Shen GL,  Tandon P,  Vedamony MM
Nat Immunol 2017 Oct 18;18(11):1175-1180
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 29044245
PMC ID: not available

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.

Wang H,  Barbieri CE,  He J,  Gao Y,  Shi T,  Wu C,  Schepmoes AA,  Fillmore TL,  Chae SS,  Huang D,  Mosquera JM,  Qian WJ,  Smith RD,  Srivastava S,  Kagan J,  Camp DG 2nd,  Rodland KD,  Rubin MA,  Liu T
J Transl Med 2017 Aug 15;15(1):175
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28810879
PMC ID: PMC5557563

A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.

Balasenthil S,  Huang Y,  Liu S,  Marsh T,  Chen J,  Stass SA,  KuKuruga D,  Brand R,  Chen N,  Frazier ML,  Jack Lee J,  Srivastava S,  Sen S,  McNeill Killary A
J Natl Cancer Inst 2017 Aug 1;109(8)
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28376184
PMC ID: PMC6059209

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Newman LA,  Stark A,  Chitale D,  Pepe M,  Longton G,  Worsham MJ,  Nathanson SD,  Miller P,  Bensenhaver JM,  Proctor E,  Swain M,  Patriotis C,  Engstrom PF
JAMA Oncol 2017 Aug 1;3(8):1102-1106
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28006062
PMC ID: PMC5796807

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

Sanda MG,  Feng Z,  Howard DH,  Tomlins SA,  Sokoll LJ,  Chan DW,  Regan MM,  Groskopf J,  Chipman J,  Patil DH,  Salami SS,  Scherr DS,  Kagan J,  Srivastava S,  Thompson IM Jr,  Siddiqui J,  Fan J,  Joon AY,  Bantis LE,  Rubin MA,  Chinnayian AM,  Wei JT,  and the EDRN-PCA3 Study Group,  Bidair M,  Kibel A,  Lin DW,  Lotan Y,  Partin A,  Taneja S
JAMA Oncol 2017 Aug 1;3(8):1085-1093
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28520829
PMC ID: PMC5710334

Systemic Metabolite Changes in Wild-type C57BL/6 Mice Fed Black Raspberries.

Pan P,  Skaer CW,  Wang HT,  Kreiser MA,  Stirdivant SM,  Oshima K,  Huang YW,  Young MR,  Wang LS
Nutr Cancer 2017 Feb-Mar;69(2):299-306
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 28094560
PMC ID: PMC5644389

Delineating Translational Innovation Pathways for Nanomedical Research Using Tech Mining

Ma J,  Zhu DH,  Farrell D,  Chang M,  Grodzinski P,  Abrams N,  Porter AL
Conference Proceeding
2017
Major Program(s) or Research Group(s): Cancer Biomarkers

Identifying translational indicators and technology opportunities for nanomedical research using tech mining: The case of gold nanostructures

Ma Jing,  Abrams Natalie F,  Porter Alan L,  Zhu Donghua,  Farrell Dorothy
Technol Forecast Soc 2017
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.

Honda K,  Srivastava S
Biomark Med 2016 Nov;10(11):1197-1207
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27673558
PMC ID: PMC5493967

Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells.

Weyemi U,  Redon CE,  Sethi TK,  Burrell AS,  Jailwala P,  Kasoji M,  Abrams N,  Merchant A,  Bonner WM
Cell Cycle 2016 Sep 16;15(18):2398-404
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27315462
PMC ID: PMC5026799

Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.

Kenner BJ,  Chari ST,  Maitra A,  Srivastava S,  Cleeter DF,  Go VL,  Rothschild LJ,  Goldberg AE
Pancreas 2016 Sep;45(8):1073-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27518362
PMC ID: PMC4993121

Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report.

Miller MS,  Allen P,  Brentnall TA,  Goggins M,  Hruban RH,  Petersen GM,  Rao CV,  Whitcomb DC,  Brand RE,  Chari ST,  Klein AP,  Lubman DM,  Rhim AD,  Simeone DM,  Wolpin BM,  Umar A,  Srivastava S,  Steele VE,  Rinaudo JA
Pancreas 2016 Sep;45(8):1080-91
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentCancer BiomarkersGastrointestinal and Other Cancers
PubMed ID: 27518363
PMC ID: PMC4988336

Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Srivastava S,  Reid BJ,  Ghosh S,  Kramer BS
J Cell Physiol 2016 Sep;231(9):1870-5
Major Program(s) or Research Group(s): Cancer Biomarkers ;  Office of the Director
PubMed ID: 26505642
PMC ID: PMC5811189

Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.

Xiao W,  Chen WW,  Sorbara L,  Davies-Hill T,  Pittaluga S,  Raffeld M,  Jaffe ES
Hum Pathol 2016 Sep;55:108-116
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 27184478
PMC ID: PMC4981556

Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.

Saud SM,  Li W,  Gray Z,  Matter MS,  Colburn NH,  Young MR,  Kim YS
Cancer Prev Res (Phila) 2016 Jul;9(7):607-15
Major Program(s) or Research Group(s): Cancer BiomarkersNutritional Science
PubMed ID: 27138790
PMC ID: PMC4930730

The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition.

Weyemi U,  Redon CE,  Choudhuri R,  Aziz T,  Maeda D,  Boufraqech M,  Parekh PR,  Sethi TK,  Kasoji M,  Abrams N,  Merchant A,  Rajapakse VN,  Bonner WM
Nat Commun 2016 Feb 15;7:10711
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26876487
PMC ID: PMC4756313

The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.

Wang M,  Devarajan K,  Singal AG,  Marrero JA,  Dai J,  Feng Z,  Rinaudo JA,  Srivastava S,  Evans A,  Hann HW,  Lai Y,  Yang H,  Block TM,  Mehta A
Cancer Prev Res (Phila) 2016 Feb;9(2):172-9
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26712941
PMC ID: PMC4740237

The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.

Wang H,  Shi T,  Qian WJ,  Liu T,  Kagan J,  Srivastava S,  Smith RD,  Rodland KD,  Camp DG 2nd
Expert Rev Proteomics 2016;13(1):99-114
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26581546
PMC ID: PMC4822694

Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients

Xao Wenbin,  Chen Wayne,  Sorbara Lynn,  Davies-Hill Theresa,  Pittaluga Stefania,  Raffeld Mark,  Jaffe Elaine S.
Blood 2015 Dec 3;126(23)
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.

Petrovics G,  Li H,  Stümpel T,  Tan SH,  Young D,  Katta S,  Li Q,  Ying K,  Klocke B,  Ravindranath L,  Kohaar I,  Chen Y,  Ribli D,  Grote K,  Zou H,  Cheng J,  Dalgard CL,  Zhang S,  Csabai I,  Kagan J,  Takeda D,  Loda M,  Srivastava S,  Scherf M,  Seifert M,  Gaiser T,  McLeod DG,  Szallasi Z,  Ebner R,  Werner T,  Sesterhenn IA,  Freedman M,  Dobi A,  Srivastava S
EBioMedicine 2015 Dec;2(12):1957-64
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26844274
PMC ID: PMC4703707

Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.

Honda K,  Kobayashi M,  Okusaka T,  Rinaudo JA,  Huang Y,  Marsh T,  Sanada M,  Sasajima Y,  Nakamori S,  Shimahara M,  Ueno T,  Tsuchida A,  Sata N,  Ioka T,  Yasunami Y,  Kosuge T,  Miura N,  Kamita M,  Sakamoto T,  Shoji H,  Jung G,  Srivastava S,  Yamada T
Sci Rep 2015 Nov 9;5:15921
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26549697
PMC ID: PMC4637825

Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.

Kelly KA,  Hollingsworth MA,  Brand RE,  Liu CH,  Singh VK,  Srivastava S,  Wasan AD,  Yadav D,  Andersen DK
Pancreas 2015 Nov;44(8):1185-94
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26465948
PMC ID: PMC4608388

Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.

Li W,  Hua B,  Saud SM,  Lin H,  Hou W,  Matter MS,  Jia L,  Colburn NH,  Young MR
Mol Carcinog 2015 Oct;54(10):1096-109
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 24838344
PMC ID: PMC4504840

The Doylestown algorithm - a test to improve the performance of AFP in the detection of early stage hepatocellular carcinoma

Mehta Anand,  Wang Mengjun,  Devarajan Karthik,  Singal Amit G.,  Marrero Jorge A.,  Feng Ziding,  Rinaudo Jo Ann,  Srivastava Sudhir,  Evans Alison,  Hann Hie-Won,  Yang Hushan,  Javaid Asad,  Poongkuran Mugilan,  Lau Daryl,  Block Timothy
Hepatology 2015 Oct;62(Suppl 1):398A-398A
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Black raspberries suppress colonic adenoma development in ApcMin/+ mice: relation to metabolite profiles.

Pan P,  Skaer CW,  Wang HT,  Stirdivant SM,  Young MR,  Oshima K,  Stoner GD,  Lechner JF,  Huang YW,  Wang LS
Carcinogenesis 2015 Oct;36(10):1245-53
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: 26246425
PMC ID: PMC4598815

ERG-based stratification of prostate cancer highlights ethnicity associated biological differences

Dobi Albert,  Degon Michael,  Farrell James,  Baptiste Wagner,  Young Denise,  Chen Yongmei,  Petrovics Gyorgy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudir,  Rosner Inger,  McLeod David G.,  Srivastava Shiv,  Sesterhenn Isabel
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 5277
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available

Analytical platform evaluation for quantification of ERG oncoprotein in prostate cancer using protein and mRNA detection methods

He Jintang,  Schepmoes Athena,  Rastogi Anshu,  Tan Shyh-Han,  Yan Wusheng,  Huang Wei,  Banerjee Sreedatta,  Shi Tujin,  Wu Chaochao,  Fillmore Thomas,  Gao Yuqian,  Kagan Jacob,  Srivastava Sudhir,  Smith Richard,  Qian Wei-Jun,  McLeod David,  Petrovics Gyorgy,  Dobi Albert,  Srinivasan Alagarsamy,  Srivastava Shiv,  Rodland Karin,  Liu Tao,  Camp David
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 1818
Major Program(s) or Research Group(s): Cancer Biomarkers
PubMed ID: not available
PMC ID: not available